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Abstract
We herein describe the positional identification of a 2-bp deletion in the open reading frame of the MRC2 receptor causing
the recessive Crooked Tail Syndrome in cattle. The resulting frame-shift reveals a premature stop codon that causes
nonsense-mediated decay of the mutant messenger RNA, and the virtual absence of functional Endo180 protein in affected
animals. Cases exhibit skeletal anomalies thought to result from impaired extracellular matrix remodeling during
ossification, and as of yet unexplained muscular symptoms. We demonstrate that carrier status is very significantly
associated with desired characteristics in the general population, including enhanced muscular development, and that the
resulting heterozygote advantage caused a selective sweep which explains the unexpectedly high frequency (25%) of
carriers in the Belgian Blue Cattle Breed.
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Introduction
The Belgian Blue Cattle breed (BBCB) is notorious for its
exceptional muscular development known as ‘‘double-muscling’’.
This extreme phenotype is due in part to an 11-bp loss-of-function
deletion in the myostatin gene that has been fixed in the breed (e.g.
[1]), as well as to ongoing selection on as of yet unidentified
polygenes influencing muscularity. As in other breeds, intense
selection has substantially reduced the effective population size.
Extensive reliance on artificial insemination (AI), in particular, by
allowing popular sires to have thousands of descendants, narrows
the genetic basis. The concomitant increase in the rate of
inbreeding causes recurrent outbreaks of recessive defects.
Inherited defects that have lately afflicted the BBCB include the
recently described Congenital Muscular Dystonias (CMD) I and II
[2].
As a result of this peculiar demography of domestic animal
populations, inherited defects generally involve unique ‘‘founder’’
mutations. Allelic homogeneity greatly facilitates positional
identification using identity-by-descent (IBD) mapping, as recently
demonstrated using the first generation high density SNP arrays
for the bovine [2]. The genes underlying CMD I & II were readily
mapped, and the causative mutations in the ATP2A1 and SLC6A5
genes identified. The widespread use of the resulting diagnostic
tests allowed immediate and effective control of the corresponding
pathologies.
We herein report the positional identification of the mutation
causing a novel, recently appeared defect referred to as Crooked
Tail Syndrome (CTS). The incidence of CTS has risen very
suddenly in the BBCB, and 25% of animals now appear to be
CTS carriers. We herein provide strong evidence for exacerbated
muscular development of carriers of the CTS mutation, conferring
‘‘heterozygote advantage’’ underlying the selective sweep that
raised the causative mutation to alarming proportions.
Results
Crooked Tail Syndrome (CTS) exhibits variable
expressivity
We recently established a heredo-surveillance platform operat-
ing in close collaboration with field veterinarians to rapidly identify
emerging genetic defects. As part of these activities, 105 CTS cases
were reported to the platform between November 2006 and
November 2007. In addition to the striking deviation of the tail
(equally likely to be dextro- or levo-rotatory), detailed clinical
examination revealed three symptoms shared by all cases: (i)
general growth retardation manifesting itself at approximately one
month of age, (ii) abnormal skull shape manifested as a shortened
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conspicuous outgrowth of the gluteus medius anchor. Additional
symptoms were observed in a substantial proportion but not all
cases: (i) spastic paresis of the hind limbs affecting either the
quadriceps only (22%), or quadriceps and gastrocnemius (14%),
often associated with straight hocks, (ii) short, straight and
extended fore limbs (33%), and (iii) pronounced scoliosis with
asymmetric development of the muscles of the back (20%). Figure 1
illustrates the corresponding symptomatology. We performed
complete necropsy of a few selected cases but detected no
additional obvious abnormalities. Moreover, radiological exami-
nation of crooked tails and scoliotic spines failed to reveal
structural defects of the vertebrae (data not shown).
Although the defect is not lethal by itself, the most severe cases
(,25%) were euthanized on welfare grounds. The surviving
,75% nevertheless caused important economic losses to their
owners as a result of growth retardation and carcass depreciation.
CTS is caused by a fully penetrant, two base pair deletion
in the open reading frame (ORF) of the MRC2 gene
We previously mapped the CTS locus to bovine chromosome 19,
in a 2.4 Mb interval shared homozygous-by-descent by the eight
analyzed CTS cases [2]. To refine the map location of the CTS
locus we genotyped the 105 reported CTS cases for five SNPs
covering the 2.4 Mb interval (Figure 2A). The SNPs were selected
on the basis of the low population frequency of the disease-
associated allele. Genotyping was achieved by first sequencing 35
pools of three animals, followed by individual sequencing of the
pools revealing the presence of the major allele and therefore of one
or more recombinants. This approach allowed us to confine the
critical region to the 812 Kb rs29010018 - AAFC03034831
interval. It comprises seven annotated genes which were ranked
on the basis of their perceived relevance with regard to the CTS
condition. Coding exons were sequenced in an affected and a
matched healthy control individual.
Author Summary
Livestock are being subject to intense artificial selection
aimed at ever-increasing, sometimes extreme, production
phenotypes. This is well-illustrated by the exceptional
muscular hypertrophy characterizing the ‘‘double-mus-
cled’’ Belgian Blue Cattle Breed (BBCB). We herein identify
a loss-of-function mutation of the bovine MRC2 gene that
increases muscle mass in heterozygotes, yet causes
skeletal and muscular malformations known as Crooked
Tail Syndrome (CTS) in homozygotes. As a result of the
‘‘heterozygote advantage’’, the MRC2 c.2904_2905delAG
mutation has swept through the BBCB population,
resulting in as many as 25% carrier animals and causing
a sudden burst of CTS cases. These findings highlight one
of the risks associated with pushing domestic animals to
their physiological limits by intense artificial selection.
Figure 1. Clinical spectrum exhibited by CTS cases. Crooked tail, growth retardation, stocky head, extreme muscular hypertrophy, spastic
paresis of the hind limbs, straight hock, scoliosis.
doi:10.1371/journal.pgen.1000666.g001
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the mannose receptor C type 2 (MRC2) gene. The MRC2 gene
encodes the 180 kDa Endocytic Transmembrane Glycoprotein
(Endo180), one of the four members of the mannose receptor
family [3,4]. Endo180 is a recycling endocytic receptor that is
predominantly expressed in mesenchymal cells such as stromal
fibroblasts and in the chondrocytes and osteoblasts/osteocytes in
the developing bones, and is proposed to play a role in regulating
extracellular matrix degradation and remodelling. It has C-type
lectin activity, binds collagen and interacts with urokinase-type
plasminogen activator receptor (uPAR) in a trimolecular cell
surface complex with pro-urokinase plasminogen activator (pro-
uPA). The 180 kD Endo180 protein comprises an aminoterminal
cysteine-rich domain of unknown function, a fibronectin type II
domain which mediates collagen binding, eight C-type lectin-like
domains (CTLDs) of which the second mediates Ca
2+-dependent
lectin activity, a stop-transfer signal anchoring this single-pass
transmembrane protein in the membrane, and a carboxyterminal
cytoplasmic domain allowing association with adaptor proteins in
the clathrin coat. The mutation identified in CTS cases is located
in exon 20 and deletes nucleotides 2904 and 2905 of the MRC2
cDNA (c.2904_2905delAG). It is predicted to append a frame-
shifted 30-residue peptide to a truncated Endo180 receptor
missing the CTLD6-8 domains, the stop-transfer signal and the
cytoplasmic domain (Figure 2B,C,D). As a result, the mutated
protein should be unable to localize to the plasma membrane and
mediate receptor-mediated endocytosis.
We developed a 59 exonuclease assay for the mutation and geno-
t y p e dt h e1 0 5r e p o r t e dC T Sc a s e s .A l lp r o v e dt ob eh o m o z y g o u sf o r
the c.2904_2905delAG mutation. We then genotyped 1,899 healthy
Belgian Blue animals. Unexpectedly, 24.7% of animals appeared to
be carriers, without a single homozygous mutant (p,10
212 assuming
Hardy-Weinberg equilibrium). Taken together, these results allowed
us to incriminate the c.2904_2905delAG mutation as being causal and
fully penetrant.
Mutant MRC2 mRNAs are targeted by the nonsense-
mediated decay (NMD) RNA surveillance pathway
C.2904_2905delAG causes a frame-shift resulting in a premature
stop codon in the 21
st of the 30-exon MRC2 gene. Mutant mRNAs
Figure 2. Positional identification of the c.2904_2905delAG MRC2 mutation causing CTS, and its effect of the Endo180 protein. (A)
Gene content of the 2.4 Mb interval in which the CTS mutation was located using identity-by-descent mapping. The triangles correspond to five SNPs
used to refine the CTS locus position, with corresponding number of recombinant individuals out of 105 CTS cases. The resulting non-recombinant
(NR) interval is marked by the red horizontal line. (B) Structure of the MRC2 gene within that interval. (C) Domain composition of the wild-type (WT)
and mutant (MUT) Endo180 protein. (D) Sequences traced obtained from genomic DNA of a homozygous wild-type, carrier and homozygous CTS
animal showing the deletion of the ApG dinucleotide in the mutant.
doi:10.1371/journal.pgen.1000666.g002
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compared the levels of wild-type and mutant MRC2 mRNA in
lung and skeletal muscle of a carrier animal by direct sequencing
of RT-PCR products encompassing the deletion. As can be seen
from Figure 3A, mutant mRNA was barely detectable. We then
compared the levels of MRC2 mRNA in lung tissue of animals of
the three genotypes using quantitative RT-PCR performed with
primer sets targeting the 59 and 39 end of the mRNA respectively.
Highly significant reductions in MRC2 mRNA levels were
observed in carriers relative to homozygous wild-type individuals
(75%64% and 45%66% of control values for the 59 and 39
systems respectively), while MRC2 mRNA levels in cases were less
than 5% of homozygous wild-types (Figure 3B). Both the allelic
imbalance and qRT-PCR experiments thus supported degrada-
tion of the mutant transcripts by NMD.
Amounts of full-length Endo180 protein are halved in
tissues of carrier animals
From the ten anti-human Endo180 antibodies tested by
Western blotting, only one polyclonal rabbit antibody (CAT2)
detected the bovine Endo180 protein with sufficient specificity.
The CAT2 antibody is directed against the last 19 amino acids of
Endo180 of which the last 18 are perfectly conserved between
human and cow [6]. CAT2 was thus predicted to allow
recognition of the wild-type but not mutant Endo180. As
expected, no wild-type Endo180 was detected in lung tissue of
CTS affected animals. In carrier animals, the levels of Endo180
protein were approximately half those observed in homozygous
wild-types (Figure 4). Assuming that Endo180 is dosage sensitive,
Figure 3. Nonsense-mediated RNA decay of c.2904_2905delAG mutant MRC2 transcripts. (A) Direct sequencing of MRC2 amplicons
spanning the CTS mutation obtained from genomic DNA and pulmonary cDNA of a heterozygous animal, showing the virtually exclusive detection of
wild-type allele amongst transcripts (the position of the deleted nucleotides is underlined in red, the sequencing direction is represented by a
triangle). (B) Comparing MRC2 mRNA levels in the lung of +/+, +/CTS and CTS/CTS animals. Data are shown for two amplicons at the 59 and 39 ends of
the mRNA, respectively. Error bars correspond to standard errors over three replicates per sample.
doi:10.1371/journal.pgen.1000666.g003
Figure 4. Effect of the CTS mutation on the levels of full-length
Endo180. Western blot results from lung of animals of the three
genotypes. Hu: human control sample. MW: molecular weight marker.
The 55 Kd band corresponds to non-specific binding of the CAT2
antibody to tubulin, used as control for the amount of protein loaded.
doi:10.1371/journal.pgen.1000666.g004
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phenotype.
CTS carrier status increases muscle mass
The unusually high frequency of the CTS mutation in BBCB
suggested that it might confer heterozygote advantage in this
highly selected population. To test this hypothesis we estimated the
effect of carrier genotype on 22 type traits evaluating muscularity,
skeletal conformation, size and leg soundness, which are
systematically recorded as part of the selection programs
implemented in the BBCB. The analysis was conducted on 519
pedigreed bulls, including 148 carrier and 371 homozygous wild-
type animals, using a mixed model including fixed effects of MRC2
genotype, year at scoring, body condition and age at scoring, as
well as a random individual animal effect. Variance components
and effects were estimated by restricted maximum likelihood
(REML) analysis. Highly significant effects were obtained for the
four categories of recorded traits (Table 1). CTS carrier animals
were smaller, stockier and more heavily muscled. They had a
thinner skeleton and more rounded ribs, which are characteristics
of beef cattle. MRC2 genotype accounted for 3.6%, 3.6% and
2.6% for the genetic variance of height, muscularity and general
appearance, respectively. These results strongly suggest that CTS
carrier frequency is increased by selection programs applied in
BBCB.
The C.2904_2905delAG mutation is undergoing a
selective sweep
To more directly demonstrate the occurrence of a selective
sweep, we performed the following analysis. Examination of the
available genealogies of the 105 affected individuals indicated that
all of them trace back to Pre ´cieux, a popular AI sire, via both sire
and dam. This suggested that Pre ´cieux, born in 1980, was CTS
carrier and that its extensive utilization in the mid eighties spread
the CTS mutation in BBCB. Genotyping Pre ´cieux and three of his
sons for the C.2904_2905delAG mutation and the 60K Illumina
chip, indeed demonstrated that he carried the CTS mutation
embedded in the SNP haplotype shared homozygous-by-descent
by the examined cases [2]. Thus, the vast majority of
C.2904_2905delAG mutations encountered in present-day BBCB
animals, trace back to Pre ´cieux.
We obtained DNA samples from all BBCB sires (174) born
between 2003 and 2005, whose semen had been commercialized
by one of the ten major Belgian AI studs. Such AI sires are heavily
selected for extreme muscularity. Examination of the pedigrees
indicated that 160 of the 174 [2003–2005] AI sires were
descendents of Pre ´cieux. The number of generations separating
these sires from Pre ´cieux averaged 5.9 (range: 3 to 8). Genotyping
the C.2904_2905delAG mutation in this cohort identified 45 CTS
carriers, all of them amongst the 160 descendents of Pre ´cieux.
Assuming that the CTS mutation indeed underwent a selective
sweep, 45 carriers out of the 160 Pre ´cieux descendants would be
significantly higher than expected by chance alone. To verify this
assumption we simulated the segregation of a mutation in the true
genealogy of the 160 descendants of Pre ´cieux and counted the
resulting number of carrier bulls. In these simulations, Pre ´cieux
was systematically assumed to be carrier, while the frequency of
the mutation in animals unrelated to Pre ´cieux varied from 0 to
0.05. In the absence of selection (i.e. if a carrier animal is equally
likely to transmit either the mutation or the wild-type allele to
anyone of its descendents), the probability to obtain 45/160
Table 1. Effect of CTS carrier status on type traits in BBCB.
Trait or syntetic note Contrast Std. error p value Carrier characteristics
SIZE Withers height 2.33 0.320 *** Smaller
Length 0.36 0.181 N.S.
Chest width 20.68 0.319 * Larger
Pelvis width 20.32 0.188 N.S.
Pelvis length 0.25 0.163 N.S.
MUSC. Shoulder muscling 20.58 0.283 * Increased muscularity
Top muscling 21.71 0.409 *** Increased muscularity
Buttock side 20.35 0.20 N.S.
Buttock rear 20.50 0.251 * Increased muscularity
Synthetic note for muscularity 20.70 0.246 ** Increased muscularity
General appearance 21.73 0.124 *** Better
SKELETAL CONFORM. Skeleton 21.18 0.386 ** Thinner
Rib shape 21.67 0.456 *** Ronder
Fore legs stance 0.54 0.157 *** More toed-in
Rear legs stance 20.43 0.200 * More toed-out
OTHER Skin 20.34 0.442 N.S.
Tail set 20.24 0.529 N.S.
Shoulder bone 0.10 0.108 N.S.
Rump 1.25 0.425 ** More horizontal
Top line 20.36 0.137 ** More convex
Hocks stance 0.84 0.367 * Straighter
*p ,5%, ** p,1%, *** p,1%.
doi:10.1371/journal.pgen.1000666.t001
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(outside the Pre ´cieux lineage) of 0.00, 0.01 and 0.05, respectively
(Table S1). Thus we can confidently assert that the
C.2904_2905delAG mutation indeed underwent a selective sweep
in the BBCB.
To have some quantitative assessment of the intensity of the
selective sweep, we repeated the ‘‘gene dropping’’ simulations
while varying the degree of segregation distortion in favour of the
mutant allele. Figure 5 shows the proportion of simulations
yielding 45/160 carrier bulls as a function of the transmission
probability of the CTS mutation from carrier parents to offspring.
It can be seen that the outcome of 45/160 carrier bulls is most
likely for a transmission rate between 0.62:0.38 (mutation
frequency outside Pre ´cieux lineage of 0.05) and 0.67:0.33
(mutation frequency outside Pre ´cieux lineage #0.01). The fact
that all 105 CST cases traced back to Pre ´cieux both on the dam
and sire side, indicates that the mutation frequency outside of the
Precieux lineage is closer to 1% than to 5%. Thus, a carrier animal
is approximately two times more likely to be selected than a non-
carrier sib.
Discussion
We herein describe a frame-shift mutation in the MRC2 gene
causing the CTS syndrome in cattle. Clinical manifestations of
CTS are dominated by skeletal and muscular anomalies. Skeletal
symptoms including growth retardation, abnormally shaped legs
and skulls, are perfectly compatible with the known involvement of
MRC2 in regulating extracellular matrix degradation and
remodeling and its strong expression in developing bone [7].
The muscular symptoms, including muscular hypertrophy, tail
deviation and spastic paresis are more difficult to rationalize,
although a role for the related mannose receptor in myoblast
motility and muscle growth has been recently reported [8]. We
cannot formally exclude the possibility that the muscular
manifestations result from distinct sequence variants in linkage
disequilibrium with the CTS mutation, although we favor the
more parsimonious hypothesis of a single causative mutation.
It is noteworthy that mice homozygous for a targeted deletion of
MRC2 exons 2 to 6 have been generated in two independent
laboratories [9,10]. Both laboratories reported that the mice were
viable and fertile, although more recently a minor deficiency in
long bone growth, bone mineral density and calvarial bone
formation has been demonstrated [7]. Cells derived from these
animals show a clear defect in collagen uptake and degradation.
One reason for the more pronounced clinical manifestations in
cattle than in mice may lie in the distinct nature of the murine and
CTS MRC2 mutations. Cells isolated from the genetically
modified mice express a mRNA species in which exon 1
(containing the signal sequence) is spliced in frame onto exon 7
(containing CTLD2), and in embryonic fibroblasts a truncated
Endo180 protein missing the cysteine-rich, FNII and CTLD1
domains can be expressed [9]. However, little or no truncated
protein is found in postnatal tissues from these knockout mice
[10,11]. Alternatively it may be that there are distinct degrees of
redundancy between members of the mannose receptor family in
different species. Also the more striking phenotype in cattle may be
due the different genetic background and particularly the fact that
the studied animals were all homozygous for a MSTN loss-of-
function mutation [1]. This hypothesis could be tested by mating
Figure 5. Distribution of the number of simulations (out of 10,000) yielding 45 carriers out of 160 Pre ´cieux descendants (Y-axis), as
a function of the rate of transmission of the mutation from heterozygous carriers (X-axis). Three curves are given corresponding to
frequencies of the mutation outside of the Pre ´cieux lineage of 0, 1, and 5%. The dotted red vertical line corresponds to a transmission rate of 67%,
maximizing the number of simulations yielding 45 carriers for a mutation frequency (outside of the Pre ´cieux lineage) of 1%, considered to be an
upper bound in BBCB.
doi:10.1371/journal.pgen.1000666.g005
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reason, at this point bovine CTS may be the more informative
model to decipher MRC2 function, and to assist in the
identification of as of yet unidentified human pathological
conditions resulting from MRC2 loss-of-function.
We provide very strong evidence of phenotypic manifestations
of the CTS mutation in carriers. This is more than likely reflecting
dosage sensitivity for Endo180, as NMD causes the mutant protein
to be present at near undetectable levels, thus very unlikely to
affect cellular function per se. Enhanced muscularity of CTS
carriers has supposedly contributed greatly to the rapid increase of
the CTS mutation in the BBCB. Indeed, we demonstrate that
carrier animals have approximately two times more chance to be
selected as elite sires than their non-carrier sibs. Note that this is
the level of segregation distortion expected for a gene that
accounts for ,5% of the genetic variance for a trait with
heritability of ,25% and assuming a selection intensity of ,2%
(Table S2).
Such selective sweep is reminiscent of the spread of other
inherited defects in domestic animals as a result of advantageous
traits exhibited by carriers. These include loss-of-function
mutations of the porcine ryanodine receptor and equine skeletal
muscle sodium channel alpha subunit gene causing, respectively,
malignant hyperthermia and hyperkalaemic periodic paralysis in
homozygotes, yet increased muscle mass in heterozygotes [12,13],
or of a FGFR3 mutation causing hereditary chondrodysplasia in
homozygous sheep and increased size in the carriers [14,15].
A diagnostic test for the CTS mutation has been developed and
already applied on more than 4,000 BBCB samples. The resulting
information should have an immediate and positive impact on the
incidence of CTS, and protect animals and breeders against the
pathological condition and ensuing economic losses.
This work is yet another illustration of the value of domestic
animal populations in enriching the phenotype-genotype map. It
adds to a recent list of positional cloning successes in poultry [16],
dog [17,18], horse [19] and bovine [2].
Materials and Methods
Mutation scanning
Coding exons of positional candidate genes were amplified from
genomic DNA of a CTS case and a matched control using standard
procedures. The primers used for the MRC2 gene are listed in Table
S3. PCR products were directly sequenced using the Big Dye
terminator cycle sequencing kit (Applied Biosystem, Foster City,
CA). Electrophoresis of purified sequencing reactions was per-
formed on an ABI PRISM 3730 DNA analyzer (PE Applied
Biosystems, Foster City, CA). Multiple sequence traces from
affected and wild-type animals were aligned and compared using
the Phred/Phrap/Consed package (www.genome.washington.edu).
59 exonuclease diagnostic assay of the CTS mutation
A Taqman assay was developed to genotype the CTS mutation,
using 59-GCG CAA CAG CAC CAG AGA-39 and 59-CTC CCT
ACC TTG TTC AGG AAC TG-39 as PCR primers, and 59-CTG
CCG CCC AC[** ] GGG-39 (CTS) and 59-CTG CCG CCC
AC[AG ]G-39 (wild type) as Taqman probes. Reactions were
carried out on a ABI7900HT instrument (Applied Biosystems,
Foster City, CA) using standard procedures.
Allelic imbalance test of NMD
Total RNA was extracted from lung, heart and skeletal muscle
of a two month old heterozygote c.2904_2905delAG animal using
Trizol (Invitrogen). The RNA was treated with TurboDNase
(Ambion). cDNA was synthesized using SuperscriptTMIII First
Strand Synthesis System for RT-PCR (Invitrogen). A portion of
MRC2 cDNA, encompassing the deletion, was amplified using
MRC2 specific primers (Table S4). The PCR products were
directly sequenced as described above.
Real-time quantitative RT-PCR test of NMD
Total RNA from lung and skeletal muscle was obtained from
animals of the three genotypes (+/+, +/CTS and CTS/CTS). After
DNase-treatment (Turbo DNA-free, Ambion), 500 ng total RNA
was reverse transcribed in a final volume of 20 ml using the iScript
cDNA Synthesis Kit (Bio-Rad). PCR reactions were performed in a
final volume of 15 ml containing 2 ml of 2.5-fold diluted cDNA
(corresponding to 20 ng of starting total RNA), 7.5 mlo f2 6master
mix prepared from the qPCR Core Kit for SYBR green I
(Eurogentec), 0.45 ml of 1/2000 SYBR green I working solution
prepared from the qPCR Core Kit for SYBR green I (Eurogentec),
forwardandreverseprimers(250 nMeach)andnucleasefreewater.
PCRs were performed on a an ABI7900HT instrument (Applied
Biosystems, Foster City, CA) under the following cycling conditions:
10 min at 95uC followed by 40 cycles at 95uC for 15 sec and 60uC
for 1 min. Two primer sets were used to test MRC2 expression
(MRC2_59QRT_UP/DN and MRC2_39QRT_UP/DN) and sev-
en genes were included as candidate endogenous controls: (1) Beta
Actin (ACTB), (2) Glyceraldehyde-3-phosphate Dehydrogenase
(GAPD), (3) Hypoxanthine Phosphoribosyltransferase 1 (HPRT1),
(4)RibosomalProteinLarge P0(RPLP0), (5)RibosomalProtein S18
(RPS18), (6) Succinate Dehydrogenase Complex Subunit A
Flavoprotein (SDHA), and (7) Tyr-3- & Trp-5-Monooxygenase
Activation Protein Beta (YWHAB). After analyse of the results with
geNorm [20], the four following genes were selected as best
endogenous controls: ACTB, RPLP0, RPS18 and YWHAB.T h e
corresponding primer sequences are given in Table S4. All sample/
gene combinations were analyzed in triplicate. Relative MRC2
expression levels, for the 59 &3 9cDNA parts, in the samples of the
three genotypes were computed using the qBase software package
(http://medgen.ugent.be/qbase/)(Hellemans et al., 2007).
Western blotting
A series of available antibodies directed against the human
Endo180 were tested by Western blotting for cross reactivity with
bovine Endo180 on commercial bovine aortic endothelial cells
(BAOEC, Cell Applications). A positive control corresponding to a
lysate of MRC5 human fibroblast cell line expressing Endo180
was included in each experiment. The tested antibodies were the
following: (i) seven mouse monoclonal antibodies (for details see
[21–23]), (ii) a rabbit polyclonal antibody (DEX) directed against
the full length human protein [21] and (iii) two rabbit polyclonal
antibodies (CAT1 and CAT2) against a peptide from the human
C-terminal cytoplasmic domain (CATEKNILVSDMEMNEQ-
QE) conjugated to KLH [6]. After initial testing, only the CAT2
antibody was retained for further experiments. Flash-frozen
skeletal muscle and lung tissues from animals of the three MRC2
genotypes (see above) were disrupted and homogenized with a
tissue lyser system II (Quiagen). Crude protein extracts were
obtained and total protein concentrations determined using a
colorimetric test (Pierce BCA Protein Assay kit, Thermo
Scientific). Fifteen mg were diluted in 15 ml final volume (16
SDS gel-loading buffer) and loaded on a 5% stacking – 10%
resolving Tris-glycine SDS-Polyacrylamide gel. Proteins were
separated by electrophoresis at 120 V-250 mA during 3 hours,
visualized by Coomassie blue staining, and electro-transferred
overnight to Hybond P PVDF membranes (GE Healthcare).
Membranes were blocked with 5% skim milk in PBS-Tween 20
Balancing Selection at the MRC2 Locus
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(1:200) in a total volume of 3 ml for 1 h30 min. After washing, the
specific signal was detected by using Alkaline Phosphatase
conjugated secondary rabbit antibodies (Sigma) following the
instructions of the manufacturer.
Statistical analysis
Phenotypes corresponded to 22 type traits related to muscularity,
skeletal conformation, size and leg soundness that are systematically
recorded in the BBCB [24]. These were analyzed using a mixed model
including genotype at the MRC2 locus (2), year at scoring (2), body
condition (4) as fixed effects, age at scoring as covariate (quadratic
regression), the additive genetic animal effect and the residual effect as
random effect [25]. The number of animals in the relationship matrix
was 6,356. Variance components were estimated using the DFREML
method (Derivative-Free Restricted Maximum Likelihood) [26]. The
part of the genetic variance due to MRC2 genotype was estimated as
the difference between the variance due to the animal model with and
without MRC2 genotype in the model. The allele substitution effects
(contrast) were calculated as the difference between the genotypic
means (+/+ and +/M) obtained from the mixed model equations.
Evidencing a selective sweep
We simulated the segregation of a heterozygous mutation from
Pre ´cieux to its 160 [2003–2005] sire offspring. Variable parameter
values were (i) the transmission rate of the mutation from carriers to
their offspring (0.5 to 0.75), (ii) the frequency of the mutation outside of
the Pre ´cieux lineage. 10,000 simulations were conducted for each set of
parameter values. Only non-affected genotypes were sampled from
matings between heterozygous parents.
Supporting Information
Table S1 Statistics of number of carriers under the neutral
model (no selection)(10,000 simulations).
Found at: doi:10.1371/journal.pgen.1000666.s001 (0.07 MB PDF)
Table S2 The table shows, for varying values of d, the
proportion of the phenotypic (P-PV) and genetic variance (P-
GV) explained by the QTN in the general population. Assume a
normally disturbed trait with 25% heritability, influenced by a
QTN with MAF 1 of 0.25 and with two possible genotypes in the
population (+/+ and +/M) as is the case for the CTS mutation.
Assume that the average phenotype of the +/+ population is -d/2
and of the +/M population is +d/2. Assume also that the residual
variance is 1. The table shows, for varying values of d, the
proportion of the phenotypic (P-PV) and genetic variance (P-GV)
explained by the QTN in the general population. Assume that one
selects future AI sires amongst offspring of popular +/M
heterozygous sires. The table shows, for five hypothetical
phenotypic threshold values for selection T=1.00–2.00, the
proportion of sons selected (Prop-Sel), and amongst the selected
sons, the ratio of carrier (+/M) versus non-carriers (+/+) (C/NC).
Dams were assumed to be +/+ for simplicity. It can be seen that
the observed ,2:1 segregation ratio observed for CTS implies a
selection intensity of the order of 0.02 for a QTN that accounts for
,0.05 of the genetic variance in the general population. The
corresponding cells are highlighted in gray.
Found at: doi:10.1371/journal.pgen.1000666.s002 (0.11 MB PDF)
Table S3 Primer pairs for the MRC2 gene.
Found at: doi:10.1371/journal.pgen.1000666.s003 (0.08 MB PDF)
Table S4 Allelic imbalance and quantitative RTPCR primer
pairs for the detection of NMD.
Found at: doi:10.1371/journal.pgen.1000666.s004 (0.08 MB PDF)
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